Skip to main content
SpringerLink
Log in

Drug-eluting stent thrombosis: it's never too late

  • Viewpoint
  • Published:

From Nature Clinical Practice Cardiovascular Medicine

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Iakovou I et al. (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293: 2126–2130

    Article  CAS  Google Scholar 

  2. Ong AT et al. (2005) Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45: 947–953

    Article  CAS  Google Scholar 

  3. Moreno R et al. (2005) Drug-eluting stent thrombosis results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45: 954–959

    Article  CAS  Google Scholar 

  4. Pfisterer ME et al. Late clinical events related to late stent thrombosis after stopping clopidogrel: prospective randomized comparison between drug-eluting versus bare-metal stenting [abstract #422–11]. Program and abstracts from the American College of Cardiology 55th Annual Scientific Session; March 11–14, 2006; Atlanta, GA.

  5. Kuchulakanti PK et al. (2006) Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113: 1108–1113

    Article  CAS  Google Scholar 

  6. Spertus JA et al. (2006) Prevalence, predictors and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER Registry. Circulation 113: 2803–2809

    Article  CAS  Google Scholar 

  7. Joner M et al. (2006) Pathology of drug-eluting stents in man: delayed healing and late thrombotic risk. J Am Coll Cardiol 48: 193–202

    Article  Google Scholar 

  8. Nebeker JR et al. (2006) Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 47: 175–181

    Article  Google Scholar 

  9. Togni M et al. (2005) Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 46: 231–236

    Article  CAS  Google Scholar 

  10. Gurbel PA et al. (2005) Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study. J Am Coll Cardiol 46: 1827–1832

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. the John B Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences at the Duke Clinical Research Institute, Durham, NC, USA

    David E Kandzari

Authors
  1. David E Kandzari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David E Kandzari.

Ethics declarations

Competing interests

The author has received research and grant support from the following organizations: Boston Scientific Corporation, Cordis Corporation, and Medtronic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kandzari, D. Drug-eluting stent thrombosis: it's never too late. Nat Rev Cardiol 3, 638–639 (2006). https://doi.org/10.1038/ncpcardio0720

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0720

  • Springer Nature Limited

Search

Navigation